JPH0543529A - Alkaneamide ammonium compound - Google Patents
Alkaneamide ammonium compoundInfo
- Publication number
- JPH0543529A JPH0543529A JP3287374A JP28737491A JPH0543529A JP H0543529 A JPH0543529 A JP H0543529A JP 3287374 A JP3287374 A JP 3287374A JP 28737491 A JP28737491 A JP 28737491A JP H0543529 A JPH0543529 A JP H0543529A
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- propyl
- compound
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003868 ammonium compounds Chemical class 0.000 title claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 47
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 20
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 7
- 125000004429 atom Chemical group 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
- 150000001450 anions Chemical class 0.000 claims abstract description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 67
- 230000003779 hair growth Effects 0.000 abstract description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 2
- -1 n-octyl group Chemical group 0.000 description 87
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- 239000002904 solvent Substances 0.000 description 47
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 42
- 229910052757 nitrogen Inorganic materials 0.000 description 33
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 29
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 150000004694 iodide salts Chemical group 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 235000019441 ethanol Nutrition 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 20
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 10
- 125000005843 halogen group Chemical group 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- 229910052740 iodine Inorganic materials 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 125000001309 chloro group Chemical group Cl* 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- SNKOFOUQKVMZFN-UHFFFAOYSA-N 5-tetradecoxypentanoic acid Chemical compound CCCCCCCCCCCCCCOCCCCC(O)=O SNKOFOUQKVMZFN-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- FKVMWDZRDMCIAJ-UHFFFAOYSA-N undecanamide Chemical compound CCCCCCCCCCC(N)=O FKVMWDZRDMCIAJ-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical group CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 2
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
- OWXXRDGGTZWLQY-UHFFFAOYSA-N 3-tetradecylsulfanylpropanoic acid Chemical compound CCCCCCCCCCCCCCSCCC(O)=O OWXXRDGGTZWLQY-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 238000006664 bond formation reaction Methods 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- RGXWDWUGBIJHDO-UHFFFAOYSA-N ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000004967 organic peroxy acids Chemical class 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- WJTCHBVEUFDSIK-NWDGAFQWSA-N (2r,5s)-1-benzyl-2,5-dimethylpiperazine Chemical compound C[C@@H]1CN[C@@H](C)CN1CC1=CC=CC=C1 WJTCHBVEUFDSIK-NWDGAFQWSA-N 0.000 description 1
- YQACAXHKQZCEOI-UDCWSGSHSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 YQACAXHKQZCEOI-UDCWSGSHSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- PTQDBSUJJKPFMY-UHFFFAOYSA-N 1-(4-bromobutoxy)tridecane Chemical compound CCCCCCCCCCCCCOCCCCBr PTQDBSUJJKPFMY-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SVZLOLOMKBBQPC-UHFFFAOYSA-N 11-(3-methylbutylsulfanyl)undecanoic acid Chemical compound CC(C)CCSCCCCCCCCCCC(O)=O SVZLOLOMKBBQPC-UHFFFAOYSA-N 0.000 description 1
- IUDGNRWYNOEIKF-UHFFFAOYSA-N 11-bromo-undecanoic acid Chemical compound OC(=O)CCCCCCCCCCBr IUDGNRWYNOEIKF-UHFFFAOYSA-N 0.000 description 1
- XZIWBORPUJQEHU-UHFFFAOYSA-N 11-cyclohexylsulfanylundecanoic acid Chemical compound OC(=O)CCCCCCCCCCSC1CCCCC1 XZIWBORPUJQEHU-UHFFFAOYSA-N 0.000 description 1
- WLCJOURNHVFPJU-UHFFFAOYSA-N 11-decylsulfanylundecanoic acid Chemical compound CCCCCCCCCCSCCCCCCCCCCC(O)=O WLCJOURNHVFPJU-UHFFFAOYSA-N 0.000 description 1
- LSEDQAPMYXQDRC-UHFFFAOYSA-N 11-dodecylsulfanylundecanoic acid Chemical compound CCCCCCCCCCCCSCCCCCCCCCCC(O)=O LSEDQAPMYXQDRC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VTHUYJIXSMGYOQ-KOORYGTMSA-N 17-hydroxyprogesterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 VTHUYJIXSMGYOQ-KOORYGTMSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- QZSZKDGRIPJPPB-UHFFFAOYSA-O 2-(11-dodecylsulfanylundecanoylamino)ethyl-diethyl-methylazanium Chemical compound C(CCCCCCCCCCC)SCCCCCCCCCCC(=O)NCC[N+](C)(CC)CC QZSZKDGRIPJPPB-UHFFFAOYSA-O 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- YNGUXAKJEVGKCF-UHFFFAOYSA-N 2-octadecylsulfanylacetic acid Chemical compound CCCCCCCCCCCCCCCCCCSCC(O)=O YNGUXAKJEVGKCF-UHFFFAOYSA-N 0.000 description 1
- ULOGAUMFSSSIHD-UHFFFAOYSA-N 2-octadecylsulfanylbutanoic acid Chemical compound CCCCCCCCCCCCCCCCCCSC(CC)C(O)=O ULOGAUMFSSSIHD-UHFFFAOYSA-N 0.000 description 1
- KZYNPINQSVKGQR-UHFFFAOYSA-N 2-octadecylsulfanylpropanoic acid Chemical compound CCCCCCCCCCCCCCCCCCSC(C)C(O)=O KZYNPINQSVKGQR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PBZOGZXSWRNCAK-UHFFFAOYSA-N 3-(11-dodecylsulfanylundecanoylamino)propyl-trimethylazanium chloride Chemical compound CCCCCCCCCCCCSCCCCCCCCCCC(=O)NCCC[N+](C)(C)C.[Cl-] PBZOGZXSWRNCAK-UHFFFAOYSA-N 0.000 description 1
- OBFSQMXGZIYMMN-UHFFFAOYSA-N 3-chloro-2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=NC=CC=C1Cl OBFSQMXGZIYMMN-UHFFFAOYSA-N 0.000 description 1
- UJCYEHJOKQZZHG-UHFFFAOYSA-N 3-methylsulfanylpropanamide Chemical compound CSCCC(N)=O UJCYEHJOKQZZHG-UHFFFAOYSA-N 0.000 description 1
- CDBQZFAWRRUUIC-UHFFFAOYSA-N 3-octadecylsulfanylpropanoic acid Chemical compound CCCCCCCCCCCCCCCCCCSCCC(O)=O CDBQZFAWRRUUIC-UHFFFAOYSA-N 0.000 description 1
- LECXDNCKDPSAFV-UHFFFAOYSA-N 3-octadecylsulfonylpropanoic acid Chemical compound CCCCCCCCCCCCCCCCCCS(=O)(=O)CCC(O)=O LECXDNCKDPSAFV-UHFFFAOYSA-N 0.000 description 1
- AQUYLDTXUNDIBO-UHFFFAOYSA-N 3-tetradecylsulfonylpropanoic acid Chemical compound CCCCCCCCCCCCCCS(=O)(=O)CCC(O)=O AQUYLDTXUNDIBO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IPCUHQYGWOKSLR-UHFFFAOYSA-N 5-aminohexanoic acid Chemical compound CC(N)CCCC(O)=O IPCUHQYGWOKSLR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- NWWWGAKVHCSAEU-UHFFFAOYSA-N 5-bromopentanenitrile Chemical compound BrCCCCC#N NWWWGAKVHCSAEU-UHFFFAOYSA-N 0.000 description 1
- XACZNFPKHPTZJL-UHFFFAOYSA-N 5-hexadecoxypentanenitrile Chemical compound CCCCCCCCCCCCCCCCOCCCCC#N XACZNFPKHPTZJL-UHFFFAOYSA-N 0.000 description 1
- FUHRXVKAOBGVCE-UHFFFAOYSA-N 5-hexadecoxypentanoic acid Chemical compound CCCCCCCCCCCCCCCCOCCCCC(O)=O FUHRXVKAOBGVCE-UHFFFAOYSA-N 0.000 description 1
- ASNCQXHWOMZMOF-UHFFFAOYSA-N 5-hexadecylsulfanylpentanoic acid Chemical compound CCCCCCCCCCCCCCCCSCCCCC(O)=O ASNCQXHWOMZMOF-UHFFFAOYSA-N 0.000 description 1
- ZPVOHOIJPXBQQK-UHFFFAOYSA-N 5-octadecoxypentanenitrile Chemical compound CCCCCCCCCCCCCCCCCCOCCCCC#N ZPVOHOIJPXBQQK-UHFFFAOYSA-N 0.000 description 1
- UCOIKSFICQXQNH-UHFFFAOYSA-N 5-octadecoxypentanoic acid Chemical compound CCCCCCCCCCCCCCCCCCOCCCCC(O)=O UCOIKSFICQXQNH-UHFFFAOYSA-N 0.000 description 1
- LQOBOPGFOJOXPN-UHFFFAOYSA-N 5-octadecylsulfanylpentanoic acid Chemical compound CCCCCCCCCCCCCCCCCCSCCCCC(O)=O LQOBOPGFOJOXPN-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- IJJALGDVUXBMCW-UHFFFAOYSA-N 5-tetradecylsulfanylpentanoic acid Chemical compound CCCCCCCCCCCCCCSCCCCC(O)=O IJJALGDVUXBMCW-UHFFFAOYSA-N 0.000 description 1
- FLRXEUFFPHLHBF-UHFFFAOYSA-N 5-tridecoxypentanoic acid Chemical compound CCCCCCCCCCCCCOCCCCC(O)=O FLRXEUFFPHLHBF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CCJBVZNALMYMMA-UHFFFAOYSA-N C(CCCCCCCCCCCCC)OC(C#N)CCC Chemical compound C(CCCCCCCCCCCCC)OC(C#N)CCC CCJBVZNALMYMMA-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- SFFHXVILVAJGQU-UHFFFAOYSA-N CCCCCCCCCCCCSCCCCCCCCCCC(NCCC[N+](C)(C)C)=O.[F-] Chemical compound CCCCCCCCCCCCSCCCCCCCCCCC(NCCC[N+](C)(C)C)=O.[F-] SFFHXVILVAJGQU-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical group COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical group CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical group [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical group OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- ZNAITCOKZPFZSA-UHFFFAOYSA-N decanamide Chemical compound CCCCCCCCCC(N)=O.CCCCCCCCCC(N)=O ZNAITCOKZPFZSA-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229960004042 diazoxide Drugs 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 1
- 229940090028 ethyl linolenate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-UHFFFAOYSA-N ethyl linolenate Natural products CCOC(=O)CCCCCCCC=CCC=CCC=CCC JYYFMIOPGOFNPK-UHFFFAOYSA-N 0.000 description 1
- JELGPLUONQGOHF-KTKRTIGZSA-N ethyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OCC JELGPLUONQGOHF-KTKRTIGZSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- HQMNCQVAMBCHCO-DJRRULDNSA-N etretinate Chemical compound CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C HQMNCQVAMBCHCO-DJRRULDNSA-N 0.000 description 1
- 229960002199 etretinate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229960003517 isothipendyl Drugs 0.000 description 1
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical compound C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- CZXGXYBOQYQXQD-UHFFFAOYSA-N methyl benzenesulfonate Chemical compound COS(=O)(=O)C1=CC=CC=C1 CZXGXYBOQYQXQD-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- 125000005527 methyl sulfate group Chemical group 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- YYZUSRORWSJGET-UHFFFAOYSA-N octanoic acid ethyl ester Natural products CCCCCCCC(=O)OCC YYZUSRORWSJGET-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- HLEKYJVHEBHTMR-UHFFFAOYSA-N pentanamide Chemical compound CCCCC(N)=O.CCCCC(N)=O HLEKYJVHEBHTMR-UHFFFAOYSA-N 0.000 description 1
- KOUCTZDKTJGHSS-UHFFFAOYSA-N pentyl 4-methylbenzenesulfonate Chemical compound CCCCCOS(=O)(=O)C1=CC=C(C)C=C1 KOUCTZDKTJGHSS-UHFFFAOYSA-N 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
(57)【要約】
【目的】 新しいタイプの発毛作用を有する化合物を提
供する。
【構成】
【化16】
[化16中、R1はアルキル基またはシクロアルキル基
を示し、R2はアルキレン基を示し、R3は水素原子ま
たはアルキル基を示し、R4はアルキレン基を示し、R
5及びR6は同一または異なってアルキル基を示し、R
7はアルキル基、アルケニル基または「フェニル基で置
換されたアルキル基」を示し、Aは酸素原子または
【化17】
(化17中、nは0〜2の整数を示す。)で表される基
を示し、Xは陰イオンとなる原子または原子団を示
す。]で表されるアルカンアミドアンモニウム化合物。(57) [Summary] [Objective] To provide a compound having a new type of hair growth action. [Structure] [Wherein R 1 represents an alkyl group or a cycloalkyl group, R 2 represents an alkylene group, R 3 represents a hydrogen atom or an alkyl group, R 4 represents an alkylene group, R 4
5 and R 6 are the same or different and each represents an alkyl group,
7 is an alkyl group, an alkenyl group or a “phenyl group-substituted alkyl group”, A is an oxygen atom or (Wherein n represents an integer of 0 to 2 in Chemical Formula 17,) X represents an atom or an atomic group which becomes an anion. ] The alkanamido ammonium compound represented by these.
Description
【0001】[0001]
【産業上の利用分野】本発明は発毛作用を有するアルカ
ンアミドアンモニウム化合物に関する。TECHNICAL FIELD The present invention relates to an alkaneamido ammonium compound having a hair growth effect.
【0002】[0002]
【従来の技術】従来、本発明の化合物に構造が類似で、
同様の作用を有する化合物は知られていない。BACKGROUND OF THE INVENTION Conventionally, the compounds of the present invention are similar in structure to
A compound having a similar action is not known.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、新し
いタイプの発毛作用を有する化合物を提供することにあ
る。The object of the present invention is to provide a compound having a new type of hair growth action.
【0004】[0004]
【課題を解決するための手段】本発明は、The present invention comprises:
【0005】[0005]
【化3】 [Chemical 3]
【0006】[化3中、R1は炭素原子数1〜22のア
ルキル基または炭素原子数3〜8のシクロアルキル基を
示し、R2は炭素原子数1〜15のアルキレン基を示
し、R3は水素原子または低級アルキル基を示し、R4
は炭素原子数2〜10のアルキレン基を示し、R5及び
R6は同一または異なって低級アルキル基を示し、R7
は炭素原子数1〜22のアルキル基、炭素原子数2〜1
0のアルケニル基または「フェニル基で置換された低級
アルキル基」を示し、Aは酸素原子または[In the chemical formula 3, R 1 represents an alkyl group having 1 to 22 carbon atoms or a cycloalkyl group having 3 to 8 carbon atoms, R 2 represents an alkylene group having 1 to 15 carbon atoms, and R 2 3 represents a hydrogen atom or a lower alkyl group, R 4
Represents an alkylene group having 2 to 10 carbon atoms, R 5 and R 6 are the same or different and represent a lower alkyl group, and R 7
Is an alkyl group having 1 to 22 carbon atoms, 2-1 carbon atoms
0 represents an alkenyl group or a “lower alkyl group substituted with a phenyl group”, A is an oxygen atom or
【化4】 (化4中、nは0〜2の整数を示す。)で表される基を
示し、Xは陰イオンとなる原子または原子団を示す。]
で表されるアルカンアミドアンモニウム化合物である。[Chemical 4] (Wherein n represents an integer of 0 to 2 in Chemical Formula 4), X represents an atom or an atomic group which becomes an anion. ]
It is an alkaneamido ammonium compound represented by.
【0007】本発明において、炭素原子数1〜22のア
ルキル基とは、メチル基、エチル基、n−プロピル基、
イソプロピル基、n−ブチル基、イソブチル基、sec
−ブチル基、tert−ブチル基、n−ペンチル基、イ
ソペンチル基、ネオペンチル基、tert−ペンチル
基、n−ヘキシル基、イソヘキシル基、n−ヘプチル
基、n−オクチル基、n−ノニル基、n−デシル基、n
−ウンデシル基、n−ドデシル基、n−トリデシル基、
n−テトラデシル基、n−ペンタデシル基、n−ヘキサ
デシル基、n−ヘプタデシル基、n−オクタデシル基、
n−ノナデシル基、n−イコシル基、n−ヘンイコシル
基、n−ドコシル基などの直鎖状または分枝鎖状のもの
をいう。In the present invention, the alkyl group having 1 to 22 carbon atoms means methyl group, ethyl group, n-propyl group,
Isopropyl group, n-butyl group, isobutyl group, sec
-Butyl group, tert-butyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, n-hexyl group, isohexyl group, n-heptyl group, n-octyl group, n-nonyl group, n- Decyl group, n
-Undecyl group, n-dodecyl group, n-tridecyl group,
n-tetradecyl group, n-pentadecyl group, n-hexadecyl group, n-heptadecyl group, n-octadecyl group,
A linear or branched chain such as an n-nonadecyl group, an n-icosyl group, an n-henicosyl group, and an n-docosyl group.
【0008】また、炭素原子数3〜8のシクロアルキル
基とは、シクロプロピル基、シクロブチル基、シクロペ
ンチル基、シクロヘキシル基、シクロヘプチル基、シク
ロオクチル基などである。炭素原子数1〜15のアルキ
レン基とは、メチレン基、エチレン基、トリメチレン
基、テトラメチレン基、ペンタメチレン基、ヘキサメチ
レン基、オクタメチレン基、ノナメチレン基、デカメチ
レン基、ウンデカメチレン基、ドデカメチレン基、トリ
デカメチレン基、ペンタデカメチレン基、プロピレン
基、1−メチル−トリメチレン基、2,2−ジメチル−
トリメチレン基、1−メチル−ヘキサメチレン基、エチ
リデン基、プロピリデン基、ブチリデン基などの直鎖状
または分枝鎖状のものをいう。炭素原子数2〜10のア
ルキレン基とは、前記炭素原子数1〜15のアルキレン
基のうち、炭素原子数2〜10のものをいう。The cycloalkyl group having 3 to 8 carbon atoms includes cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group and the like. The alkylene group having 1 to 15 carbon atoms means methylene group, ethylene group, trimethylene group, tetramethylene group, pentamethylene group, hexamethylene group, octamethylene group, nonamethylene group, decamethylene group, undecamethylene group, dodecamethylene. Group, tridecamethylene group, pentadecamethylene group, propylene group, 1-methyl-trimethylene group, 2,2-dimethyl-
A straight-chain or branched-chain group such as trimethylene group, 1-methyl-hexamethylene group, ethylidene group, propylidene group and butylidene group. The alkylene group having 2 to 10 carbon atoms means an alkylene group having 2 to 10 carbon atoms among the alkylene groups having 1 to 15 carbon atoms.
【0009】低級アルキル基とは、メチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
イソブチル基、n−ペンチル基などの、炭素原子数1〜
5の直鎖状または分枝鎖状のアルキル基をいう。炭素原
子数2〜10のアルケニル基とは、ビニル基、アリル
基、1−ブチニル基、プレニル基、ゲラニル基などであ
る。フェニル基で置換された低級アルキル基とは、ベン
ジル基、フェニルエチル基、フェニルプロピル基などの
フェニル基で置換された炭素原子数1〜5の直鎖状また
は分枝鎖状のアルキル基である。The lower alkyl group means a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group,
1 to 1 carbon atoms such as isobutyl group and n-pentyl group
5 refers to a linear or branched alkyl group. The alkenyl group having 2 to 10 carbon atoms includes vinyl group, allyl group, 1-butynyl group, prenyl group, geranyl group and the like. The lower alkyl group substituted with a phenyl group is a linear or branched alkyl group having 1 to 5 carbon atoms which is substituted with a phenyl group such as a benzyl group, a phenylethyl group and a phenylpropyl group. ..
【0010】陰イオンとなる原子または原子団として
は、フッ素原子、塩素原子、臭素原子、ヨウ素原子、硫
酸基、硝酸基、亜硝酸基、硫酸メチル基、硫酸エチル
基、リン酸ジメチル基、メタンスルホン酸基、ベンゼン
スルホン酸基、p−トルエンスルホン酸基などを用いる
ことができる。The atom or atomic group to be an anion includes fluorine atom, chlorine atom, bromine atom, iodine atom, sulfate group, nitrate group, nitrite group, methyl sulfate group, ethyl sulfate group, dimethyl phosphate group, methane. A sulfonic acid group, a benzenesulfonic acid group, a p-toluenesulfonic acid group, or the like can be used.
【0011】本発明の化合物は、例えば以下に示す方法
に従って製造することができる(以下、R1,R2,R
3,R4,R5,R6,R7,A及びnの記号は特に断
らない限り前記と同意義に用いる。)。すなわち、ま
ず、The compound of the present invention can be produced, for example, according to the following method (hereinafter, R 1 , R 2 and R
The symbols of 3 , R 4 , R 5 , R 6 , R 7 , A and n have the same meanings as described above unless otherwise specified. ). That is, first,
【化5】 で表される化合物と[Chemical 5] And a compound represented by
【化6】 で表されるアミンを、通常のアミド結合生成反応を用い
て反応させることにより、[Chemical 6] By reacting an amine represented by with a usual amide bond formation reaction,
【化7】 で表される化合物を得ることができる。[Chemical 7] A compound represented by can be obtained.
【0012】ここで、アミド結合生成反応としては通常
のアミド結合生成反応の条件を適用することができる。
例えば、(イ)加熱脱水する方法、(ロ)酸ハライド
法、(ハ)混合酸無水物法、(ニ)活性エステル法、
(ホ)カルボジイミド法などを用いることができるが、
(イ)または(ロ)の方法を用いることが好ましい。 (イ)の方法は、無溶媒または溶媒存在下、1モルの水
が留去するまで行うもので、無溶媒で行う場合には反応
温度は通常130〜200℃程度、好ましくは150〜
170℃で行い、溶媒存在下で行う場合には溶媒の沸点
で行う。溶媒は反応に悪影響を与えない、水と共沸する
ものを使用することができ、例えばキシレンなどを挙げ
ることができる。 (ロ)の方法は、化5の化合物にハロゲン化剤を作用さ
せて得た酸ハライドと化6の化合物を反応させる方法で
ある。すなわち、化5の化合物と等モル量〜大過剰量の
ハロゲン化剤(例えば、塩化チオニル、五塩化リン、オ
キシ塩化リン、塩化オキサリル、臭化チオニル、三臭化
リンなど)を無溶媒または不活性溶媒(例えば、ベンゼ
ン、トルエン、テトラヒドロフラン、塩化メチレン、ク
ロロホルムなど)中、室温〜溶媒の沸点で0.5〜10
時間撹拌することにより化5の化合物の酸ハライドを
得、これと化6の化合物を無溶媒または溶媒(例えば塩
化メチレン、クロロホルム、四塩化炭素などのハロゲン
化炭化水素類、ジエチルエーテル、テトラヒドロフラ
ン、ジオキサンなどのエーテル類、ベンゼン、トルエ
ン、キシレンなどの芳香族炭化水素類、酢酸メチル、酢
酸エチルなどのエステル類、N,N−ジメチルホルムア
ミド、ジメチルスルホキシドなどの非プロトン性極性溶
媒など)存在下で−30〜100℃程度(好ましくは0
〜50℃)で反応させるものである。ここで、前半の反
応においては必ずしも触媒を必要としないが、ピリジ
ン、トリエチルアミン、N,N−ジメチルホルムアミド
などを触媒量〜等モル量添加することにより反応を促進
することができる。Here, as the amide bond forming reaction, usual conditions for the amide bond forming reaction can be applied.
For example, (a) heat dehydration method, (b) acid halide method, (c) mixed acid anhydride method, (d) active ester method,
(E) The carbodiimide method or the like can be used,
It is preferable to use the method (a) or (b). The method (a) is carried out without solvent or in the presence of a solvent until 1 mol of water is distilled off. When the method is carried out without solvent, the reaction temperature is usually about 130 to 200 ° C., preferably 150 to
It is carried out at 170 ° C., and when carried out in the presence of a solvent, it is carried out at the boiling point of the solvent. A solvent that does not adversely affect the reaction and that is azeotropic with water can be used, and examples thereof include xylene. The method (b) is a method of reacting the compound of formula 6 with an acid halide obtained by reacting the compound of formula 5 with a halogenating agent. That is, a halogenating agent (e.g., thionyl chloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride, thionyl bromide, phosphorus tribromide, etc.) in an equimolar amount to a large excess amount with the compound of Chemical formula 5 is used with or without a solvent. 0.5-10 at room temperature to the boiling point of the solvent in an active solvent (eg, benzene, toluene, tetrahydrofuran, methylene chloride, chloroform, etc.)
The acid halide of the compound of Chemical formula 5 is obtained by stirring for a period of time, and this compound and the compound of Chemical formula 6 are used with or without a solvent (for example, halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, diethyl ether, tetrahydrofuran, dioxane). Etc., ethers such as benzene, aromatic hydrocarbons such as benzene, toluene and xylene, esters such as methyl acetate and ethyl acetate, and aprotic polar solvents such as N, N-dimethylformamide and dimethyl sulfoxide) 30 to 100 ° C (preferably 0
˜50 ° C.). Here, a catalyst is not necessarily required in the first half reaction, but the reaction can be promoted by adding pyridine, triethylamine, N, N-dimethylformamide and the like in catalytic amounts to equimolar amounts.
【0013】次いで、化7の化合物とThen, with the compound of
【化8】 (化8中、Yはハロゲン原子を示す。)で表される化合
物、鉱酸エステル(この場合、エステル部分はR7の基
である。)または有機酸エステル(この場合、エステル
部分はR7の基である。)を無溶媒または溶媒中で反応
させる4級化反応によって本発明の化合物を得ることが
できる。ここで、ハロゲン原子としては塩素原子、臭素
原子またはヨウ素原子を用いることができる。また、鉱
酸エステル及び有機酸エステルとしては、硫酸ジメチ
ル、硫酸ジエチル、リン酸トリメチル、メタンスルホン
酸メチル、ベンゼンスルホン酸メチル、p−トルエンス
ルホン酸メチル、p−トルエンスルホン酸ペンチルなど
を用いることができる。溶媒としては水、アセトン、ア
ルコール類(例えばメタノール、エタノールなど)、ジ
エチルエーテル、ベンゼン、アセトニトリルなどを用い
ることができる。反応温度は0℃〜溶媒の沸点である。[Chemical 8] (Wherein Y represents a halogen atom), a mineral acid ester (in this case, the ester moiety is a group of R 7 ), or an organic acid ester (in this case, the ester moiety is R 7). The compound of the present invention can be obtained by a quaternization reaction in which a group of 4) is reacted with or without a solvent. Here, a chlorine atom, a bromine atom or an iodine atom can be used as the halogen atom. As the mineral acid ester and the organic acid ester, dimethyl sulfate, diethyl sulfate, trimethyl phosphate, methyl methanesulfonate, methyl benzenesulfonate, methyl p-toluenesulfonate, pentyl p-toluenesulfonate and the like can be used. it can. As the solvent, water, acetone, alcohols (eg, methanol, ethanol, etc.), diethyl ether, benzene, acetonitrile, etc. can be used. The reaction temperature is from 0 ° C to the boiling point of the solvent.
【0014】また、化3の化合物においてAが化4の基
であり、さらにnが1または2である化合物は、前記の
方法により得た化7の化合物(Aが化4の基であり、さ
らにnが0のもの)を溶媒中、1〜3倍モル量の酸化剤
と反応させた後、以下、前記の方法と同様にして反応さ
せることにより製造することもできる。ここで、酸化剤
としては過酸化水素、有機過酸(例えば、過酢酸、トリ
フルオロ過酢酸、過安息香酸、過フタル酸、m−クロル
過安息香酸など)などを用いることができる。また、溶
媒としては水、塩化メチレン、クロロホルム、ジクロロ
エタン、ベンゼン、トルエン、酢酸エチル、酢酸などを
用いることができる。反応温度は−30〜150℃であ
る。In the compound of the chemical formula 3, A is a group of the chemical formula 4, and n is 1 or 2, and the compound of the chemical formula 7 obtained by the above-mentioned method (A is the group of the chemical formula 4, Further, it can also be produced by reacting (in which n is 0) in a solvent with a 1- to 3-fold molar amount of an oxidizing agent, and then reacting it in the same manner as the above method. Here, hydrogen peroxide, organic peracid (eg, peracetic acid, trifluoroperacetic acid, perbenzoic acid, perphthalic acid, m-chloroperbenzoic acid, etc.) can be used as the oxidizing agent. As the solvent, water, methylene chloride, chloroform, dichloroethane, benzene, toluene, ethyl acetate, acetic acid or the like can be used. The reaction temperature is -30 to 150 ° C.
【0015】さらに、化3の化合物においてXがフッ素
原子、塩素原子、臭素原子、硫酸基、硝酸基、亜硝酸基
である化合物は次の方法によっても製造することができ
る。すなわち、前記の方法によって製造した本発明の化
合物の1つである、Further, in the compound of Chemical formula 3, a compound in which X is a fluorine atom, a chlorine atom, a bromine atom, a sulfuric acid group, a nitric acid group or a nitrite group can also be produced by the following method. That is, one of the compounds of the present invention produced by the above method,
【化9】 で表される化合物と、ヨウ素イオンとイオン交換する銀
塩(フッ化銀、塩化銀、臭化銀、硫酸銀、硝酸銀または
亜硝酸銀)を、溶媒中、室温〜溶媒の沸点で反応させる
ことにより、化3の化合物においてXがフッ素原子、塩
素原子、臭素原子、硫酸基、硝酸基、亜硝酸基である化
合物を得ることができる。ここで、溶媒としては水、ア
ルコール類(例えばメタノール、エタノールなど)及び
これらの混合溶媒などを用いることができる。[Chemical 9] By reacting a compound represented by with a silver salt (silver fluoride, silver chloride, silver bromide, silver sulfate, silver nitrate or silver nitrite) that exchanges ions with iodine ions, in a solvent at room temperature to the boiling point of the solvent. In the compound of Chemical formula 3, a compound in which X is a fluorine atom, a chlorine atom, a bromine atom, a sulfate group, a nitrate group, or a nitrite group can be obtained. Here, as the solvent, water, alcohols (for example, methanol, ethanol, etc.), a mixed solvent thereof, or the like can be used.
【0016】ところで、出発物質である化5の化合物は
以下のような方法で公知の化合物から製造することがで
きる。 (1)化5の化合物においてAが化4の基であり、さら
にnが0である化合物の場合By the way, the compound of Chemical formula 5, which is a starting material, can be produced from a known compound by the following method. (1) In the compound of Chemical formula 5, A is a group of Chemical formula 4, and n is 0
【化10】 で表されるチオール化合物と、[Chemical 10] A thiol compound represented by
【化11】 (化11中、Z1はハロゲン原子を示す。)で表される
化合物を塩基存在下、溶媒中、0℃〜溶媒の沸点で0.
5〜10時間撹拌させることにより、Aが化4の基であ
り、さらにnが0である化5の化合物を得ることができ
る。ここで、ハロゲン原子としては塩素原子、臭素原子
またはヨウ素原子を用いることができる。また、塩基と
しては水酸化ナトリウム、水酸化カリウム、炭酸ナトリ
ウム、炭酸カリウム、トリエチルアミンなどを用いるこ
とができる。溶媒としては水、アルコール類(例えばメ
タノール、エタノールなど)、アセトン、N,N−ジメ
チルホルムアミド、アセトニトリル、ジオキサン、テト
ラヒドロフランなどを用いることができる。さらに、ヨ
ウ化カリウムなどの反応促進剤を添加することもでき
る。[Chemical 11] (Wherein Z 1 represents a halogen atom in Chemical formula 11), in the presence of a base, at 0 ° C. to the boiling point of the solvent at 0 ° C.
By stirring for 5 to 10 hours, a compound of Chemical formula 5 in which A is a group of Chemical formula 4 and n is 0 can be obtained. Here, a chlorine atom, a bromine atom or an iodine atom can be used as the halogen atom. As the base, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, triethylamine, etc. can be used. As the solvent, water, alcohols (eg, methanol, ethanol, etc.), acetone, N, N-dimethylformamide, acetonitrile, dioxane, tetrahydrofuran and the like can be used. Furthermore, a reaction accelerator such as potassium iodide may be added.
【0017】(2)化5の化合物においてAが化4の基
であり、さらにnが1または2である化合物の場合 前記(1)の方法により得た、Aが化4の基であり、さ
らにnが0である化5の化合物を溶媒中、1〜3倍モル
量の酸化剤と反応させることにより、Aが化4の基であ
り、さらにnが1または2である化5の化合物を得るこ
とができる。ここで、酸化剤としては過酸化水素、有機
過酸(例えば、過酢酸、トリフルオロ過酢酸、過安息香
酸、過フタル酸、m−クロル過安息香酸など)などを用
いることができる。また、溶媒としては水、塩化メチレ
ン、クロロホルム、ジクロロエタン、ベンゼン、トルエ
ン、酢酸エチル、酢酸などを用いることができる。反応
温度は−30〜150℃である。(2) In the compound of Chemical formula 5, A is the group of Chemical formula 4 and n is 1 or 2, and A is the group of Chemical formula 4 obtained by the method of the above (1), Furthermore, by reacting a compound of Chemical formula 5 in which n is 0 with a 1 to 3 molar amount of an oxidizing agent in a solvent, a compound of Chemical formula 5 in which A is a group of Chemical formula 4 and n is 1 or 2 Can be obtained. Here, hydrogen peroxide, organic peracid (eg, peracetic acid, trifluoroperacetic acid, perbenzoic acid, perphthalic acid, m-chloroperbenzoic acid, etc.) can be used as the oxidizing agent. As the solvent, water, methylene chloride, chloroform, dichloroethane, benzene, toluene, ethyl acetate, acetic acid or the like can be used. The reaction temperature is -30 to 150 ° C.
【0018】(3)化5の化合物においてAが酸素原子
である化合物の場合(3) In the compound of Chemical formula 5, A is an oxygen atom
【化12】 で表されるアルコールと、[Chemical formula 12] Alcohol represented by
【化13】 (化13中、Z2はハロゲン原子を示す。)で表される
化合物を塩基存在下、溶媒中、0℃〜溶媒の沸点で1〜
48時間撹拌させることにより、Aが酸素原子である化
5の化合物を得ることができる。ここで、ハロゲン原子
としては塩素原子、臭素原子またはヨウ素原子を用いる
ことができる。また、塩基としては水酸化ナトリウム、
水酸化カリウム、炭酸ナトリウム、炭酸カリウム、水素
化ナトリウム、ナトリウムアミド、トリエチルアミン、
酸化バリウム、酸化銀などを用いることができる。溶媒
としては水、アセトン、エーテル、テトラヒドロフラ
ン、N,N−ジメチルホルムアミド、ジメチルスルホキ
シド、1,2−ジメトキシエタン、アセトニトリル、ジ
オキサンなどを用いることができる。さらに、ヨウ化カ
リウムなどの反応促進剤を添加することもできる。[Chemical 13] (In Chemical formula 13, Z 2 represents a halogen atom), in the presence of a base, in a solvent, at 0 ° C. to the boiling point of the solvent, 1 to
By stirring for 48 hours, a compound of Chemical formula 5 in which A is an oxygen atom can be obtained. Here, a chlorine atom, a bromine atom or an iodine atom can be used as the halogen atom. Also, as the base, sodium hydroxide,
Potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, sodium amide, triethylamine,
Barium oxide, silver oxide or the like can be used. As the solvent, water, acetone, ether, tetrahydrofuran, N, N-dimethylformamide, dimethyl sulfoxide, 1,2-dimethoxyethane, acetonitrile, dioxane or the like can be used. Furthermore, a reaction accelerator such as potassium iodide may be added.
【0019】また、化12の化合物とFurther, with the compound of
【化14】 (化14中、Z3及びZ4は同一または異なってハロゲ
ン原子を示す。)で表される化合物を塩基存在下、溶媒
(例えば水、アセトン、エーテル、テトラヒドロフラ
ン、N,N−ジメチルホルムアミド、ジメチルスルホキ
シド、1,2−ジメトキシエタンなど)中、0℃〜溶媒
の沸点で1〜48時間撹拌させてハロゲン化エーテルと
し、次いでこれを溶媒(エーテル、テトラヒドロフラン
など)中、マグネシウムと反応させてグリニャール試薬
とした後、二酸化炭素と反応させることにより、Aが酸
素原子である化5の化合物を得ることもできる。ここ
で、ハロゲン原子としては塩素原子、臭素原子またはヨ
ウ素原子を用いることができる。また、塩基としては水
酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭
酸カリウム、水素化ナトリウム、ナトリウムアミド、ト
リエチルアミン、酸化バリウム、酸化銀などを用いるこ
とができる。[Chemical 14] (In the formula 14, Z 3 and Z 4 are the same or different and each represents a halogen atom.) The compound represented by In sulfoxide, 1,2-dimethoxyethane, etc.), the mixture is stirred at 0 ° C. to the boiling point of the solvent for 1 to 48 hours to give a halogenated ether, which is then reacted with magnesium in a solvent (ether, tetrahydrofuran, etc.) to produce a Grignard reagent. Then, by reacting with carbon dioxide, it is possible to obtain a compound of Chemical formula 5 in which A is an oxygen atom. Here, a chlorine atom, a bromine atom or an iodine atom can be used as the halogen atom. As the base, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, sodium amide, triethylamine, barium oxide, silver oxide or the like can be used.
【0020】さらには、化12の化合物とFurther, with the compound of
【化15】 (化15中、Z5はハロゲン原子を示す。)で表される
化合物を塩基(例えば水酸化ナトリウム、水酸化カリウ
ム、炭酸ナトリウム、炭酸カリウム、水素化ナトリウ
ム、ナトリウムアミド、トリエチルアミン、酸化バリウ
ム、酸化銀など)存在下、溶媒(例えば水、アセトン、
エーテル、テトラヒドロフラン、N,N−ジメチルホル
ムアミド、ジメチルスルホキシド、1,2−ジメトキシ
エタンなど)中、0℃〜溶媒の沸点で1〜48時間撹拌
させてエーテルニトリル化合物とし、次いでこれを加水
分解することにより、Aが酸素原子である化5の化合物
を得ることもできる。ここで、ハロゲン原子としては塩
素原子、臭素原子またはヨウ素原子を用いることができ
る。また、前記加水分解は酸または塩基存在下、溶媒
中、室温〜溶媒の沸点で1〜12時間撹拌することによ
り行う。ここで酸としては塩酸、硫酸、酢酸、ギ酸など
を用いることができ、塩基としては水酸化ナトリウム、
水酸化カリウム、水酸化バリウムなどを用いることがで
きる。溶媒としては水、含水アルコール類(例えばメタ
ノール水溶液、エタノール水溶液など)を用いることが
できる。[Chemical 15] (Wherein Z 5 represents a halogen atom in Chemical formula 15) is converted into a base (for example, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, sodium amide, triethylamine, barium oxide, oxidation). In the presence of a solvent such as water, acetone,
Ether, tetrahydrofuran, N, N-dimethylformamide, dimethylsulfoxide, 1,2-dimethoxyethane, etc.) at 0 ° C. to the boiling point of the solvent for 1 to 48 hours to give an ether nitrile compound, which is then hydrolyzed Thus, a compound of Chemical formula 5 in which A is an oxygen atom can also be obtained. Here, a chlorine atom, a bromine atom or an iodine atom can be used as the halogen atom. The hydrolysis is performed by stirring in a solvent at room temperature to the boiling point of the solvent for 1 to 12 hours in the presence of an acid or a base. Here, hydrochloric acid, sulfuric acid, acetic acid, formic acid or the like can be used as the acid, and sodium hydroxide as the base.
Potassium hydroxide, barium hydroxide or the like can be used. As the solvent, water or hydrous alcohols (eg, methanol aqueous solution, ethanol aqueous solution) can be used.
【0021】化3の化合物の投与量及び投与方法である
が、化3の化合物の1種または2種以上を例えば通常の
基剤を用いてローション、乳液、クリーム、ゲル、エア
ゾールなどの外用剤とし、これを1日数回、適量頭皮に
塗布する。また、この製剤には他の薬効物質を配合する
ことができる。Regarding the dose and method of administration of the compound of formula 3, one or two or more compounds of formula 3 are used, for example, an external preparation such as lotion, emulsion, cream, gel, aerosol, etc. using a common base. And apply this to the scalp several times a day. In addition, other medicinal substances can be added to this preparation.
【0022】上記における通常の基剤及び他の薬効物質
としては、例えば溶媒(エチルアルコール、イソプロピ
ルアルコール、1,3−ブチレングリコール、1,4−
ブチレングリコール、プロピレングリコール、ジプロピ
レングリコール、グリセリン、ジグリセリン、ポリエチ
レングリコール、精製水など)、ムコ多糖類(ヒアルロ
ン酸、コンドロイチン−4−硫酸、コンドロイチン−6
−硫酸、デルマタン硫酸、ケラタン硫酸、ヘパラン硫
酸、コンドロイチン硫酸エステルの多硫酸エステルな
ど)、保存剤(パラベン、安息香酸など)、ビタミン類
[ビタミンA、ビタミンB1、ビタミンB2、ビタミン
B6、ビタミンC、ビタミンD、ビタミンE及びそれら
の誘導体(例えばビタミンE酢酸エステルなど)]、油
分(流動パラフィン、白色ワセリン、固形パラフィン、
セレシン、マイクロクリスタリンワックス、コレステロ
ール、スクワラン、オリーブ油、ローズヒップ油、ミン
ク油、ホホバ油、硬化ヒマシ油、硬化ヤシ油、ミリスチ
ン酸イソプロピル、カプリン酸エチル、カプリル酸エチ
ル、パルミトレイン酸、パルミトレイン酸エチル、リノ
ール酸エチル、リノレン酸エチル、オレイン酸、ステア
リン酸、リノール酸、リノレン酸、パルミチン酸、ベヘ
ニン酸、ラウリン酸、ステアリルアルコール、セチルア
ルコール、ラウリルアルコール、オレイルアルコール、
イソオクタン酸セチルなど)、殺菌剤[硫黄、グルコン
酸クロルヘキシジン、塩酸クロルヘキシジン、塩化セチ
ルピリジン、塩化デカリニウム、イソプロピルメチルフ
ェノール、第4級アンモニウム塩(例えば塩化ベンザル
コニウムなど)、ヒノキチオールなど]、非イオン性界
面活性剤(ポリオキシエチレン脂肪酸エステル、ポリオ
キシエチレンソルビタン脂肪酸エステル、ソルビタン脂
肪酸エステル、グリセリン脂肪酸エステル、ポリオキシ
エチレングリセリン脂肪酸エステル、ポリグリセリン脂
肪酸エステル、プロピレングリコール脂肪酸エステル、
ポリグリセリンアルキルフェニルエーテル、ポリオキシ
エチレン硬化ヒマシ油、ポリオキシエチレンとポリプロ
ピリングリコールの共重合体など)、陰イオン性界面活
性剤(N−アシルアミノ酸塩、N−アシルサルコシン
塩、アルキルリン酸エステル塩、アシルメチルタウリン
塩など)、陽イオン性界面活性剤(アルキルトリメチル
アンモニウム、アルキル−N,N−ジアルキルアミノ酢
酸エステルなど)、両性界面活性剤(イミダゾリン、ア
ミンオキシドなど)、高分子界面活性剤(カゼインな
ど)、シリコーン誘導体(シリコーンオイル、ポリオー
ル変性シリコーン、シリコーン樹脂など)、増粘剤(メ
チルセルロース、ポリビニルピロリドン、カルボキシメ
チルセルロース、カルボキシエチルセルロース、ヒドロ
キシプロピルセルロース、カルボキシビニルポリマーな
ど)、粘土鉱物(モンモリロナイト、サポナイト、ヘク
トライトなど)、pH調整剤(ジイソプロパノールアミ
ン、クエン酸など)、酸化防止剤(ジブチルヒドロキシ
トルエン、亜硫酸水素ナトリウム、カテキン、グルクノ
デルタラクトンなど)、美白剤(アルブチン、コウジ酸
など)、清涼化剤(1−メントール、カンフルなど)、
抗炎症剤(グリチルレチン酸、グリチルリチン酸ジカリ
ウム、塩化ベルベリン、シコニン、グアイアズレン、ア
ラントイン、δ−アミノカプロン酸など)、末梢血管拡
張剤(ニコチン酸メチル、ニコチン酸ベンジル、シュエ
ルチアマリン、ミノキシジル、ジアゾキシド、トウガラ
シエキス、カプサイシン、塩化カルプロニウムなど)、
副腎皮質ホルモン(酢酸ハイドロコーチゾン、吉草酸ベ
タメタゾンなど)、抗ヒスタミン剤(塩酸ジフェンヒド
ラミン、塩酸イソチペンジルなど)、局所麻酔剤(塩酸
ジブカイン、塩酸リドカインなど)、角質溶解剤(尿
素、サリチル酸など)、角化調整剤[ビタミンA酸及び
その誘導体(例えば13−シス−レチノイン酸、エトレ
チネートなど)]、卵胞ホルモン(17β−エストラジ
オール、エチニルエストラジオール、エストロンな
ど)、黄体ホルモン(プロゲステロン、17α−ヒドロ
キシプロゲステロンアセテートなど)、抗アンドロゲン
剤(シプロテロンアセテート、4−アンドロステン−3
−オン−17β−カルボキシリックアシッドなど)、香
料、金属イオン封鎖剤、紫外線吸収剤、保湿剤(へちま
抽出物、ニンジンエキス、ジイソプロピルアセテート、
ピロリドンカルボン酸、ポリグルタミン酸、ポリオキシ
アルキレンアルキルグルコシドエーテル、コラーゲン、
レシチン、セラミド、2−アミノエタンスルホン酸な
ど)、生薬エキス(かしゅうエキス、竹節人参エキス、
ランジックエキス、サフランエキスなど)などを挙げる
ことができる。Examples of the usual bases and other medicinal substances mentioned above include solvents (ethyl alcohol, isopropyl alcohol, 1,3-butylene glycol, 1,4-
Butylene glycol, propylene glycol, dipropylene glycol, glycerin, diglycerin, polyethylene glycol, purified water, etc., mucopolysaccharide (hyaluronic acid, chondroitin-4-sulfate, chondroitin-6)
-Sulfuric acid, dermatan sulfate, keratan sulfate, heparan sulfate, polysulfate of chondroitin sulfate, etc.), preservatives (paraben, benzoic acid, etc.), vitamins [vitamin A, vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 6 , Vitamin C, vitamin D, vitamin E and derivatives thereof (for example, vitamin E acetate ester)], oil (liquid paraffin, white petrolatum, solid paraffin,
Ceresin, microcrystalline wax, cholesterol, squalane, olive oil, rosehip oil, mink oil, jojoba oil, hydrogenated castor oil, hydrogenated coconut oil, isopropyl myristate, ethyl caprate, ethyl caprylate, palmitoleic acid, ethyl palmitoleate, linole. Ethyl acid, ethyl linolenate, oleic acid, stearic acid, linoleic acid, linolenic acid, palmitic acid, behenic acid, lauric acid, stearyl alcohol, cetyl alcohol, lauryl alcohol, oleyl alcohol,
Cetyl isooctanoate, etc.), bactericides [sulfur, chlorhexidine gluconate, chlorhexidine hydrochloride, cetyl pyridine chloride, decalinium chloride, isopropylmethylphenol, quaternary ammonium salts (such as benzalkonium chloride), hinokitiol], nonionic Surfactants (polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester,
Polyglycerin alkyl phenyl ether, polyoxyethylene hydrogenated castor oil, copolymer of polyoxyethylene and polypropyrin glycol, etc., anionic surfactant (N-acyl amino acid salt, N-acyl sarcosine salt, alkyl phosphate ester) Salt, acylmethyl taurine salt, etc.), cationic surfactant (alkyl trimethyl ammonium, alkyl-N, N-dialkylaminoacetic acid ester etc.), amphoteric surfactant (imidazoline, amine oxide etc.), polymer surfactant (Casein etc.), Silicone derivative (Silicone oil, Polyol modified silicone, Silicone resin etc.), Thickener (Methylcellulose, Polyvinylpyrrolidone, Carboxymethylcellulose, Carboxyethylcellulose, Hydroxypropyl cellulose) , Carboxyvinyl polymers, etc.), clay minerals (montmorillonite, saponite, hectorite, etc.), pH adjusters (diisopropanolamine, citric acid, etc.), antioxidants (dibutylhydroxytoluene, sodium bisulfite, catechin, glucnodeltalactone) Etc.), whitening agents (arbutin, kojic acid, etc.), cooling agents (1-menthol, camphor, etc.),
Anti-inflammatory agents (glycyrrhetinic acid, dipotassium glycyrrhizinate, berberine chloride, shikonin, guaiazulene, allantoin, δ-aminocaproic acid, etc.), peripheral vasodilators (methyl nicotinate, benzyl nicotinate, cheliamarin, minoxidil, diazoxide, capsicum extract) , Capsaicin, carpronium chloride, etc.),
Corticosteroids (hydrocortisone acetate, betamethasone valerate, etc.), antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.), local anesthetics (dibucaine hydrochloride, lidocaine hydrochloride, etc.), keratolytic agents (urea, salicylic acid, etc.), keratinization regulators [Vitamin A acid and its derivatives (eg, 13-cis-retinoic acid, etretinate, etc.)], estrogen (17β-estradiol, ethinylestradiol, estrone, etc.), progesterone (progesterone, 17α-hydroxyprogesterone acetate, etc.), antiandrogen Agents (cyproterone acetate, 4-androstene-3
-On-17β-carboxylic acid, etc.), fragrance, sequestering agent, ultraviolet absorber, moisturizer (hechima extract, carrot extract, diisopropyl acetate,
Pyrrolidone carboxylic acid, polyglutamic acid, polyoxyalkylene alkyl glucoside ether, collagen,
Lecithin, ceramide, 2-aminoethanesulfonic acid, etc., herbal medicine extract (Kamuyu extract, Ginseng extract,
Langicic extract, saffron extract, etc.) and the like.
【0023】[0023]
【発明の効果】本発明の化合物は優れた発毛作用を有す
るので、発毛剤として有用である。The compound of the present invention has an excellent hair-growth action and is useful as a hair-growth agent.
【0024】[0024]
【実施例】以下、製造例、実施例及び試験例を挙げて本
発明を更に詳細に説明する。 (実施例) 製造例111−(ドデシルチオ)ウンデカン酸 ドデシルメルカプタン101.2g、11−ブロモウン
デカン酸132.6g及びエタノール300mlの混合
物に、60℃撹拌下、水酸化ナトリウム40.0gの水
溶液120mlを滴下し、3時間還流した。冷却後3N
塩酸を加えて酸性とし、クロロホルムで抽出後、水、飽
和食塩水の順で洗浄し、無水硫酸ナトリウムで乾燥し
た。溶媒を留去後生成物をクロロホルムで再結晶するこ
とにより標記化合物174.5gを得た。 m.p.69〜71℃EXAMPLES The present invention will be described in more detail with reference to production examples, examples and test examples. Example 1 Production Example 1 A mixture of 101.2 g of dodecyl mercaptan 11- (dodecylthio) undecanoate, 132.6 g of 11-bromoundecanoic acid and 300 ml of ethanol was stirred at 60 ° C. and 120 ml of an aqueous solution of 40.0 g of sodium hydroxide was added. It was dropped and refluxed for 3 hours. 3N after cooling
The mixture was acidified with hydrochloric acid, extracted with chloroform, washed with water and saturated brine in that order, and dried over anhydrous sodium sulfate. After distilling off the solvent, the product was recrystallized from chloroform to obtain 174.5 g of the title compound. m. p. 69-71 ° C
【0025】製造例1と同様にして以下の化合物を得
た。 11−(イソペンチルチオ)ウンデカン酸 m.p.47〜49℃ 11−(シクロヘキシルチオ)ウンデカン酸 m.p.46〜48℃ 11−(デシルチオ)ウンデカン酸 m.p.63〜65℃ 3−(テトラデシルチオ)プロピオン酸 m.p.66〜68℃ 5−(テトラデシルチオ)吉草酸 m.p.59〜61℃ 5−(ヘキサデシルチオ)吉草酸 m.p.65〜67℃ (オクタデシルチオ)酢酸 m.p.73〜75℃ 3−(オクタデシルチオ)プロピオン酸 m.p.78〜80℃ 2−(オクタデシルチオ)プロピオン酸 m.p.65〜67℃ 2−(オクタデシルチオ)酪酸 m.p.55〜57℃ 5−(オクタデシルチオ)吉草酸 m.p.72〜74℃The following compounds were obtained in the same manner as in Production Example 1. 11- (isopentylthio) undecanoic acid m. p. 47-49 ° C. 11- (Cyclohexylthio) undecanoic acid m. p. 46-48 ° C. 11- (decylthio) undecanoic acid m. p. 63-65 ° C. 3- (tetradecylthio) propionic acid m.p. p. 66-68 ° C. 5- (tetradecylthio) valeric acid m.p. p. 59-61 ° C. 5- (Hexadecylthio) valeric acid m.p. p. 65-67 ° C. (octadecylthio) acetic acid m.p. p. 73-75 ° C. 3- (octadecylthio) propionic acid m.p. p. 78-80 ° C 2- (octadecylthio) propionic acid m.p. p. 65-67 ° C 2- (octadecylthio) butyric acid m.p. p. 55-57 ° C 5- (octadecylthio) valeric acid m.p. p. 72-74 ° C
【0026】製造例23−(テトラデシルスルホニル)プロピオン酸 製造例1と同様にして得た3−(テトラデシルチオ)プ
ロピオン酸5.2gを塩化メチレン70mlに溶解し、
室温撹拌下、塩化メチレン70mlに溶解したm−クロ
ロ過安息香酸8.9gを滴下し、室温で66時間撹拌し
た。析出した結晶を▲ろ▼取し、シリカゲルを用いたカ
ラムクロマトグラフィーで精製し、酢酸エチルから再結
晶することにより標記化合物2.5gを得た。 m.p.136〜138℃ 製造例2と同様にして以下の化合物を得た。 3−(オクタデシルスルホニル)プロピオン酸 m.p.135〜137℃Production Example 2 3- (tetradecylsulfonyl ) propionic acid 5.2 g of 3- (tetradecylthio) propionic acid obtained in the same manner as in Production Example 1 was dissolved in 70 ml of methylene chloride,
Under room temperature stirring, 8.9 g of m-chloroperbenzoic acid dissolved in 70 ml of methylene chloride was added dropwise, and the mixture was stirred at room temperature for 66 hours. The precipitated crystals were collected by filtration, purified by column chromatography using silica gel, and recrystallized from ethyl acetate to obtain 2.5 g of the title compound. m. p. 136-138 ° C The following compound was obtained in the same manner as in Production Example 2. 3- (octadecylsulfonyl) propionic acid m. p. 135-137 ° C
【0027】製造例35−(トリデシルオキシ)吉草酸 (1)1−トリデカノール28.0g、1,4−ジブロ
モブタン60.5g及び硫酸水素テトラ−n−ブチルア
ンモニウム0.4gに、40%水酸化ナトリウム水溶液
56mlを加え、室温で一晩撹拌した。エーテルで抽出
後、無水硫酸マグネシウムで乾燥し、溶媒を留去後、減
圧蒸留することにより1−(4−ブロモブトキシ)トリ
デカン11.7gを得た。 b.p.148〜149℃/0.80mmHg (2)マグネシウム2.4gに、テトラヒドロフラン2
0ml及び小片量のヨウ素を加え、アルゴン気流下、ヨ
ウ素の色が消えるまで還流した。この反応液に、還流
下、(1)で得た化合物26.8gのテトラヒドロフラ
ン30ml溶液を滴下し、さらに30分間還流した。−
5℃に冷却し、ドライアイス150gを反応液が0℃よ
り上昇しないように加え、さらに室温で1時間撹拌し
た。25%硫酸100mlを加えて加水分解した後、エ
ーテルで抽出し、20%水酸化ナトリウム水溶液でアル
カリ性として水相を分取し、再び酸性にしてクロロホル
ムで抽出し、無水硫酸マグネシウムで乾燥した。減圧下
溶媒を留去し、標記化合物11.8gを得た。 m.p.43〜44℃Preparation Example 3 5- ( Tridecyloxy ) valeric acid (1) 28.0 g, 1,4-dibromobutane 60.5 g and tetra-n-butylammonium hydrogensulfate 0.4 g were added to 40%. 56 ml of an aqueous sodium hydroxide solution was added, and the mixture was stirred overnight at room temperature. After extraction with ether and drying over anhydrous magnesium sulfate, the solvent was distilled off and the residue was distilled under reduced pressure to obtain 11.7 g of 1- (4-bromobutoxy) tridecane. b. p. 148-149 ° C / 0.80 mmHg (2) Magnesium 2.4 g, tetrahydrofuran 2
0 ml and a small amount of iodine were added, and the mixture was refluxed under an argon stream until the color of iodine disappeared. A solution of 26.8 g of the compound obtained in (1) in 30 ml of tetrahydrofuran was added dropwise to this reaction solution, and the mixture was refluxed for 30 minutes. −
The mixture was cooled to 5 ° C., 150 g of dry ice was added so that the reaction liquid did not rise above 0 ° C., and the mixture was further stirred at room temperature for 1 hour. After hydrolyzing by adding 100 ml of 25% sulfuric acid, the mixture was extracted with ether, made alkaline with a 20% aqueous sodium hydroxide solution, and the aqueous phase was separated, acidified again, extracted with chloroform, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 11.8 g of the title compound. m. p. 43-44 ° C
【0028】製造例45−(テトラデシルオキシ)吉草酸 (1)1−テトラデカノール15.0gをテトラヒドロ
フラン70ml溶液に溶解し、氷冷下5−ブロモペンタ
ンニトリル12.2ml及び96%水酸化カリウム粉末
4.9gを加えた。室温で24時間撹拌後、酢酸エチル
を加え、反応液を飽和食塩水で洗浄後、無水硫酸マグネ
シウムで乾燥した。減圧下、溶媒を留去し、残渣をシリ
カゲルカラムクロマトグラフィー(展開溶媒;エーテ
ル:n−ヘキサン=1:4)で精製することにより5−
(テトラデシルオキシ)ペンタンニトリル7.4gを得
た。 m.p.30〜31℃ 製造例4(1)と同様にして以下の化合物を得た。 5−(ヘキサデシルオキシ)ペンタンニトリル m.p.40〜41℃ 5−(オクタデシルオキシ)ペンタンニトリル m.p.46〜47℃Production Example 4 5- ( Tetradecyloxy ) valeric acid (1) 1-tetradecanol (15.0 g) was dissolved in a solution of 70 ml of tetrahydrofuran, and under ice-cooling 12.2 ml of 5-bromopentanenitrile and 96% hydroxylation. 4.9 g of potassium powder was added. After stirring at room temperature for 24 hours, ethyl acetate was added, the reaction solution was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent; ether: n-hexane = 1: 4) to give 5-
7.4 g of (tetradecyloxy) pentanenitrile was obtained. m. p. 30 to 31 ° C. The following compound was obtained in the same manner as in Production Example 4 (1). 5- (hexadecyloxy) pentanenitrile m. p. 40-41 ° C 5- (octadecyloxy) pentanenitrile m. p. 46-47 ° C
【0029】(2)(1)で得た化合物8.6gをエタ
ノール50mlに溶解し、25%水酸化カリウム水溶液
50mlを加え、8時間還流した。冷却後、濃塩酸を加
えて酸性とし、酢酸エチルで抽出した。飽和食塩水で洗
浄後、無水硫酸マグネシウムで乾燥し、減圧下溶媒を留
去することにより標記化合物8.6gを得た。 m.p. 56〜57℃ 製造例4(2)と同様にして以下の化合物を得た。 5−(ヘキサデシルオキシ)吉草酸 m.p.64〜65℃ 5−(オクタデシルオキシ)吉草酸 m.p.68〜69℃(2) 8.6 g of the compound obtained in (1) was dissolved in 50 ml of ethanol, 50 ml of 25% aqueous potassium hydroxide solution was added, and the mixture was refluxed for 8 hours. After cooling, concentrated hydrochloric acid was added to acidify, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure to give the title compound (8.6 g). m. p. 56-57 ° C The following compound was obtained in the same manner as in Production Example 4 (2). 5- (hexadecyloxy) valeric acid m. p. 64-65 ° C 5- (octadecyloxy) valeric acid m.p. p. 68-69 ° C
【0030】製造例5N−[3−(ジメチルアミノ)プロピル]−11−(ド
デシルチオ)ウンデカンアミド 製造例1で得た11−(ドデシルチオ)ウンデカン酸1
50.0gとN,N−ジメチル−1,3−ジアミノプロ
パン47.6gをキシレン200ml中、生成する水を
除きながら5時間還流した。冷却後生成物を▲ろ▼取
し、メチルエチルケトンで再結晶することにより標記化
合物153.3gを得た。 m.p.68〜70℃Production Example 5 N- [3- (dimethylamino) propyl] -11- (d
Decylthio) undecanoamide 11- (dodecylthio) undecanoic acid 1 obtained in Preparation Example 1
50.0 g and 47.6 g of N, N-dimethyl-1,3-diaminopropane were refluxed in 200 ml of xylene for 5 hours while removing generated water. After cooling, the product was collected by filtration and recrystallized from methyl ethyl ketone to obtain 153.3 g of the title compound. m. p. 68-70 ° C
【0031】製造例1〜4で製造した化合物を用いて、
製造例5と同様にして以下の化合物を得た。 N−[3−(ジメチルアミノ)プロピル]−11−(イ
ソペンチルチオ)ウンデカンアミド m.p.47〜49℃ N−[3−(ジメチルアミノ)プロピル]−11−(シ
クロヘキシルチオ)ウンデカンアミド m.p.61〜63℃ N−[3−(ジメチルアミノ)プロピル]−11−(デ
シルチオ)ウンデカンアミド m.p.62〜64℃ N−[2−(ジメチルアミノ)エチル]−11−(ドデ
シルチオ)ウンデカンアミド m.p.71〜73℃ N−[2−(ジエチルアミノ)エチル]−11−(ドデ
シルチオ)ウンデカンアミド m.p.63〜65℃ N−[3−(ジエチルアミノ)プロピル]−11−(ド
デシルチオ)ウンデカンアミド m.p.59〜61℃ N−[2,2−ジメチル−3−(ジメチルアミノ)プロ
ピル]−11−(ドデシルチオ)ウンデカンアミド m.p.59〜61℃ N−[3−(ジメチルアミノ)プロピル]−3−(テト
ラデシルチオ)プロパンアミド m.p.46〜48℃ N−[3−(ジメチルアミノ)プロピル]−3−(テト
ラデシルスルホニル)プロパンアミド m.p.89〜91℃ N−[3−(ジメチルアミノ)プロピル]−5−(テト
ラデシルチオ)ペンタンアミド m.p.58〜60℃Using the compounds produced in Production Examples 1 to 4,
The following compounds were obtained in the same manner as in Production Example 5. N- [3- (dimethylamino) propyl] -11- (isopentylthio) undecanamide m. p. 47-49 ° C. N- [3- (Dimethylamino) propyl] -11- (cyclohexylthio) undecane amide m.p. p. 61-63 ° C. N- [3- (dimethylamino) propyl] -11- (decylthio) undecanamide m.p. p. 62-64 ° C. N- [2- (dimethylamino) ethyl] -11- (dodecylthio) undecanamide m.p. p. 71-73 ° C N- [2- (diethylamino) ethyl] -11- (dodecylthio) undecanamide m.p. p. 63-65 ° C. N- [3- (diethylamino) propyl] -11- (dodecylthio) undecanamide m.p. p. 59-61 ° C. N- [2,2-dimethyl-3- (dimethylamino) propyl] -11- (dodecylthio) undecanamide m.p. p. 59-61 ° C N- [3- (dimethylamino) propyl] -3- (tetradecylthio) propanamide m.p. p. 46-48 ° C N- [3- (dimethylamino) propyl] -3- (tetradecylsulfonyl) propanamide m.p. p. 89-91 ° C. N- [3- (dimethylamino) propyl] -5- (tetradecylthio) pentanamide m.p. p. 58-60 ° C
【0032】N−[3−(ジメチルアミノ)プロピル]
−5−(ヘキサデシルチオ)ペンタンアミド m.p.68〜70℃ N−[3−(ジメチルアミノ)プロピル]−2−(オク
タデシルチオ)アセトアミド m.p.53〜55℃ N−[3−(ジメチルアミノ)プロピル]−3−(オク
タデシルチオ)プロパンアミド m.p.58〜60℃ N−[3−(ジメチルアミノ)プロピル]−3−(オク
タデシルスルホニル)プロパンアミド m.p.98〜100℃ N−[2−(ジメチルアミノ)エチル]−5−(オクタ
デシルチオ)ペンタンアミド m.p.72〜74℃ N−[3−(ジメチルアミノ)プロピル]−5−(オク
タデシルチオ)ペンタンアミド m.p.68〜70℃ N−[3−(ジメチルアミノ)プロピル]−5−(テト
ラデシルオキシ)ペンタンアミド m.p.53〜54℃ N−[2−(ジメチルアミノ)エチル]−5−(トリデ
シルオキシ)ペンタンアミド m.p.52〜53℃ N−[3−(ジメチルアミノ)プロピル]−5−(トリ
デシルオキシ)ペンタンアミド m.p.46〜47℃ N−[2−(ジメチルアミノ)エチル]−5−(テトラ
デシルオキシ)ペンタンアミド m.p.58〜59℃ N−[3−(ジメチルアミノ)プロピル]−5−(ヘキ
サデシルオキシ)ペンタンアミド m.p.58〜59℃ N−[3−(ジメチルアミノ)プロピル]−5−(オク
タデシルオキシ)ペンタンアミド m.p.66〜67℃N- [3- (dimethylamino) propyl]
-5- (hexadecylthio) pentanamide m. p. 68-70 ° C. N- [3- (dimethylamino) propyl] -2- (octadecylthio) acetamide m.p. p. 53-55 ° C. N- [3- (dimethylamino) propyl] -3- (octadecylthio) propanamide m.p. p. 58-60 ° C N- [3- (Dimethylamino) propyl] -3- (octadecylsulfonyl) propanamide m.p. p. 98-100 ° C. N- [2- (dimethylamino) ethyl] -5- (octadecylthio) pentanamide m.p. p. 72-74 ° C. N- [3- (dimethylamino) propyl] -5- (octadecylthio) pentanamide m.p. p. 68-70 ° C. N- [3- (dimethylamino) propyl] -5- (tetradecyloxy) pentanamide m.p. p. 53-54 ° C. N- [2- (dimethylamino) ethyl] -5- (tridecyloxy) pentanamide m.p. p. 52-53 ° C. N- [3- (dimethylamino) propyl] -5- (tridecyloxy) pentanamide m.p. p. 46-47 ° C. N- [2- (dimethylamino) ethyl] -5- (tetradecyloxy) pentanamide m.p. p. 58-59 ° C N- [3- (Dimethylamino) propyl] -5- (hexadecyloxy) pentanamide m.p. p. 58-59 ° C N- [3- (Dimethylamino) propyl] -5- (octadecyloxy) pentanamide m.p. p. 66-67 ° C
【0033】製造例6N−[3−(ジメチルアミノ)プロピル]−3−(メチ
ルチオ)プロパンアミド 3−(メチルチオ)プロピオン酸4.3gをトルエン4
0mlに溶解し、塩化チオニル8.5gを加え、80℃
で3時間撹拌した。減圧下、トルエンと過剰の塩化チオ
ニルを留去し、粗クロリドを得た。これをクロロホルム
10mlに溶解し、氷冷撹拌下、N,N−ジメチル−
1,3−ジアミノプロパン3.7gのクロロホルム20
ml溶液に滴下し、さらに室温で16時間撹拌した。こ
の反応液を飽和重曹水、水、飽和食塩水の順で洗浄し、
無水硫酸ナトリウムで乾燥した。減圧下で溶媒を留去
し、油液状の標記化合物6.0gを得た。1 H−NMR(CDCl3) δ(ppm);1.75
(2H,quint.,J=6.3Hz),2.14
(3H,s),2.35(6H,s),2.43〜2.
61(4H,m),2.80(2H,t,J=6.9H
z),3.37(2H,quart.,J=6.0H
z),7.22(1H,br.s)Production Example 6 N- [3- (dimethylamino) propyl] -3- (meth)
Luthio) propanamide 3- (methylthio) propionic acid 4.3 g was added to toluene 4
Dissolve in 0 ml, add 8.5 g of thionyl chloride, and add 80 ° C.
It was stirred for 3 hours. Toluene and excess thionyl chloride were distilled off under reduced pressure to obtain crude chloride. This was dissolved in 10 ml of chloroform, and N, N-dimethyl-
1,3-diaminopropane 3.7 g chloroform 20
The solution was added dropwise to the ml solution and further stirred at room temperature for 16 hours. This reaction solution was washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline in this order,
It was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to obtain 6.0 g of the title compound as an oily liquid. 1 H-NMR (CDCl 3 ) δ (ppm); 1.75
(2H, quint., J = 6.3Hz), 2.14
(3H, s), 2.35 (6H, s), 2.43-2.
61 (4H, m), 2.80 (2H, t, J = 6.9H
z), 3.37 (2H, quart., J = 6.0H)
z), 7.22 (1H, br.s)
【0034】製造例7N−[3−(ジメチルアミノ)プロピル]−11−(ド
デシルスルフィニル)ウンデカンアミド 製造例5で得たN−[3−(ジメチルアミノ)プロピ
ル]−11−(ドデシルチオ)ウンデカンアミド1.0
gをクロロホルム50mlに溶解し、氷冷撹拌下、クロ
ロホルム15mlに溶解したm−クロロ過安息香酸0.
5gを滴下し、さらに氷冷下で4時間撹拌した。この反
応液を飽和重曹水、水、飽和食塩水の順で洗浄し、無水
硫酸ナトリウムで乾燥した。溶媒を留去後、生成物をク
ロロホルム−エーテルで再結晶することにより標記化合
物0.91gを得た。 m.p.110〜112℃Production Example 7 N- [3- (dimethylamino) propyl] -11- (d
Decyl sulfinyl) obtained in undecanamide Preparation 5 N-[3- (dimethylamino) propyl] -11-(dodecylthio) undecanamide 1.0
g of m-chloroperbenzoic acid dissolved in 15 ml of chloroform under ice-cooling stirring.
5 g was added dropwise, and the mixture was further stirred under ice cooling for 4 hours. The reaction solution was washed with saturated aqueous sodium hydrogen carbonate, water and saturated brine in this order, and dried over anhydrous sodium sulfate. After distilling off the solvent, the product was recrystallized from chloroform-ether to obtain 0.91 g of the title compound. m. p. 110-112 ° C
【0035】実施例1N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド 製造例5で得たN−[3−(ジメチルアミノ)プロピ
ル]−11−(ドデシルチオ)ウンデカンアミド12
0.0gをエタノール1Lに溶解し、ヨウ化メチル5
2.4gを加え室温で3日間撹拌した。生成物を▲ろ▼
取し、エタノールで再結晶することにより標記化合物1
41.5gを得た。 m.p.103〜105℃1 H−NMR(CDCl3) δ(ppm)=;0.8
8(3H,t,J=6.5Hz),1.19〜1.71
(36H,m),2.06〜2.24(2H,m),
2.32(2H,t,J=7.5Hz),2.50(4
H,t,J=7.4Hz),3.32〜3.49(11
H,m),3.80〜3.93(2H,m),7.30
〜7.41(1H,m)Example 1 N- {3- [11- (dodecylthio) undecanaami
De] propyl} -N, N, N-trimethylammonium
= N- [3- (dimethylamino) propyl] -11- (dodecylthio) undecanamide 12 obtained in Iodide Production Example 5
Dissolve 0.0 g in 1 L of ethanol, and add methyl iodide 5
2.4 g was added and the mixture was stirred at room temperature for 3 days. The product
The title compound 1 was obtained by taking and recrystallizing with ethanol.
41.5 g was obtained. m. p. 103-105 ° C 1 H-NMR (CDCl 3 ) δ (ppm) =; 0.8
8 (3H, t, J = 6.5Hz), 1.19 to 1.71
(36H, m), 2.06 to 2.24 (2H, m),
2.32 (2H, t, J = 7.5Hz), 2.50 (4
H, t, J = 7.4 Hz), 3.32 to 3.49 (11
H, m), 3.80 to 3.93 (2H, m), 7.30
~ 7.41 (1H, m)
【0036】実施例1と同様にして以下の化合物を得
た。 N−{3−[3−(メチルチオ)プロパンアミド]プロ
ピル}−N,N,N−トリメチルアンモニウム=ヨーダ
イド m.p.118〜120℃ N−{2−[N′−メチル−3−(メチルチオ)プロパ
ンアミド]エチル}−N,N,N−トリメチルアンモニ
ウム=ヨーダイド m.p.132〜134℃ N−{3−[11−(イソペンチルチオ)ウンデカンア
ミド]プロピル}−N,N,N−トリメチルアンモニウ
ム=ヨーダイド m.p.98〜100℃ N−{3−[11−(シクロヘキシルチオ)ウンデカン
アミド]プロピル}−N,N,N−トリメチルアンモニ
ウム=ヨーダイド m.p.101〜103℃ N−{3−[11−(デシルチオ)ウンデカンアミド]
プロピル}−N,N,N−トリメチルアンモニウム=ヨ
ーダイド m.p.99〜101℃ N−{2−[11−(ドデシルチオ)ウンデカンアミ
ド]エチル}−N,N,N−トリメチルアンモニウム=
ヨーダイド m.p.115〜117℃ N−{2−[11−(ドデシルチオ)ウンデカンアミ
ド]エチル}−N,N−ジエチル−N−メチルアンモニ
ウム=ヨーダイド m.p.75〜77℃ N−{3−[11−(ドデシルスルフィニル)ウンデカ
ンアミド]プロピル}−N,N,N−トリメチルアンモ
ニウム=ヨーダイド m.p.123〜125℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N−ジエチル−N−メチルアンモ
ニウム=ヨーダイド m.p.88〜90℃ N−{2,2−ジメチル−3−[11−(ドデシルチ
オ)ウンデカンアミド]プロピル}−N,N,N−トリ
メチルアンモニウム=ヨーダイド m.p.127〜129℃ N−{3−[3−(テトラデシルチオ)プロパンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.116〜118℃ N−{3−[3−(テトラデシルスルホニル)プロパン
アミド]プロピル}−N,N,N−トリメチルアンモニ
ウム=ヨーダイド m.p.76〜78℃ N−{3−[5−(テトラデシルチオ)ペンタンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.91〜93℃ N−{3−[5−(ヘキサデシルチオ)ペンタンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.95〜97℃ N−{3−[3−(オクタデシルチオ)プロパンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.116〜118℃ N−{3−[3−(オクタデシルスルホニル)プロパン
アミド]プロピル}−N,N,N−トリメチルアンモニ
ウム=ヨーダイド m.p.96〜98℃ N−{3−[2−(オクタデシルチオ)プロパンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.131〜133℃ N−{2−[5−(オクタデシルチオ)ペンタンアミ
ド]エチル}−N,N,N−トリメチルアンモニウム=
ヨーダイド m.p.88〜90℃ N−{3−[5−(オクタデシルチオ)ペンタンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.96〜98℃The following compounds were obtained in the same manner as in Example 1. N- {3- [3- (methylthio) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 118-120 ° C. N- {2- [N′-methyl-3- (methylthio) propanamide] ethyl} -N, N, N-trimethylammonium = iodide m.p. p. 132-134 ° C. N- {3- [11- (isopentylthio) undecanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 98-100 ° C. N- {3- [11- (cyclohexylthio) undecanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 101-103 ° C. N- {3- [11- (decylthio) undecanamide]
Propyl} -N, N, N-trimethylammonium = iodide m.p. p. 99-101 ° C. N- {2- [11- (dodecylthio) undecanamido] ethyl} -N, N, N-trimethylammonium =
Iodide m. p. 115-117 ° C. N- {2- [11- (dodecylthio) undecanamido] ethyl} -N, N-diethyl-N-methylammonium = iodide m.p. p. 75-77 ° C. N- {3- [11- (dodecylsulfinyl) undecanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 123-125 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N-diethyl-N-methylammonium = iodide m.p. p. 88-90 ° C. N- {2,2-dimethyl-3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 127-129 ° C. N- {3- [3- (tetradecylthio) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 116-118 ° C. N- {3- [3- (tetradecylsulfonyl) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 76-78 ° C. N- {3- [5- (tetradecylthio) pentanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 91-93 ° C. N- {3- [5- (hexadecylthio) pentanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 95-97 ° C. N- {3- [3- (octadecylthio) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 116-118 ° C. N- {3- [3- (octadecylsulfonyl) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 96-98 ° C. N- {3- [2- (octadecylthio) propanamide] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 131-133 ° C. N- {2- [5- (octadecylthio) pentanamido] ethyl} -N, N, N-trimethylammonium =
Iodide m. p. 88-90 ° C. N- {3- [5- (octadecylthio) pentanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 96-98 ° C
【0037】実施例2N−{3−[5−(テトラデシルオキシ)ペンタンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド 製造例5と同様にして得たN−[3−(ジメチルアミ
ノ)プロピル]−5−(テトラデシルオキシ)ペンタン
アミド2.5gをエタノール10mlに溶解し、ヨウ化
メチル0.6mlを加え、室温で24時間撹拌した。減
圧下、溶媒を留去後、生成物をエタノール−エーテルで
再結晶することにより標記化合物2.9gを得た。 m.p.94〜96℃1 H−NMR(CDCl3) δ(ppm);0.88
(3H,t,J=6.5Hz),1.26(22H,
s),1.46〜1.78(6H,m),2.03〜
2.22(2H,m),2.34(2H,t,J=7.
0Hz),3.32〜3.48(15H,m),3.7
8〜3.91(2H,m),7.17〜7.27(1
H,m)Example 2 N- {3- [5- (tetradecyloxy) pentanami
De] propyl} -N, N, N-trimethylammonium
= 2.5 g of N- [3- (dimethylamino) propyl] -5- (tetradecyloxy) pentanamide obtained in the same manner as in Iodide Production Example 5 was dissolved in 10 ml of ethanol, and 0.6 ml of methyl iodide was added. The mixture was stirred at room temperature for 24 hours. The solvent was distilled off under reduced pressure, and the product was recrystallized from ethanol-ether to obtain 2.9 g of the title compound. m. p. 94-96 ° C 1 H-NMR (CDCl 3 ) δ (ppm); 0.88
(3H, t, J = 6.5Hz), 1.26 (22H,
s), 1.46 to 1.78 (6H, m), 2.03 to
2.22 (2H, m), 2.34 (2H, t, J = 7.
0 Hz), 3.32 to 3.48 (15H, m), 3.7
8 to 3.91 (2H, m), 7.17 to 7.27 (1
H, m)
【0038】実施例2と同様にして以下の化合物を得
た。 N−{2−[5−(トリデシルオキシ)ペンタンアミ
ド]エチル}−N,N,N−トリメチルアンモニウム=
ヨーダイド m.p.91〜92℃ N−{3−[5−(トリデシルオキシ)ペンタンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.96〜98℃ N−{2−[5−(テトラデシルオキシ)ペンタンアミ
ド]エチル}−N,N,N−トリメチルアンモニウム=
ヨーダイド m.p.93〜94℃ N−{3−[5−(ヘキサデシルオキシ)ペンタンアミ
ド]ブロピル}−N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.98〜100℃ N−{3−[5−(オクタデシルオキシ)ペンタンアミ
ド]プロピル},N,N,N−トリメチルアンモニウム
=ヨーダイド m.p.101〜103℃The following compounds were obtained in the same manner as in Example 2. N- {2- [5- (tridecyloxy) pentanamido] ethyl} -N, N, N-trimethylammonium =
Iodide m. p. 91-92 ° C. N- {3- [5- (tridecyloxy) pentanamido] propyl} -N, N, N-trimethylammonium = iodide m.p. p. 96-98 ° C. N- {2- [5- (tetradecyloxy) pentanamido] ethyl} -N, N, N-trimethylammonium =
Iodide m. p. 93-94 ° C. N- {3- [5- (hexadecyloxy) pentanamide] bropyr} -N, N, N-trimethylammonium = iodide m.p. p. 98-100 ° C. N- {3- [5- (octadecyloxy) pentanamido] propyl}, N, N, N-trimethylammonium = iodide m.p. p. 101-103 ° C
【0039】実施例3N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ブロマイド 製造例5で得たN−[3−(ジメチルアミノ)プロピ
ル]−11−(ドデシルチオ)ウンデカンアミド1.5
gをエタノール100mlに溶解し、臭化メチル0.8
gを加え室温で4日間撹拌した。溶媒を留去後エタノー
ルで再結晶することにより標記化合物1.2gを得た。 m.p.92〜94℃1 H−NMR(CDCl3) δ(ppm);0.88
(3H,t,J=6.5Hz),1.20〜1.74
(36H,m),2.11〜2.29(2H,m),
2.40〜2.56(6H,m),3.31〜3.53
(11H,m),3.89〜4.04(2H,m),
8.62(1H,br.s)Example 3 N- {3- [11- (dodecylthio) undecanaami ]
De] propyl} -N, N, N-trimethylammonium
= N- [3- (dimethylamino) propyl] -11- (dodecylthio) undecanamide 1.5 obtained in Production Example 5 of bromide
g was dissolved in 100 ml of ethanol, and methyl bromide 0.8
g was added and the mixture was stirred at room temperature for 4 days. The solvent was distilled off and the residue was recrystallized from ethanol to obtain 1.2 g of the title compound. m. p. 92~94 ℃ 1 H-NMR (CDCl 3) δ (ppm); 0.88
(3H, t, J = 6.5Hz), 1.20 to 1.74
(36H, m), 2.11 to 2.29 (2H, m),
2.40 to 2.56 (6H, m), 3.31 to 3.53
(11H, m), 3.89 to 4.04 (2H, m),
8.62 (1H, br.s)
【0040】実施例4N−ベンジル−N−{3−[11−(デシルチオ)ウン
デカンアミド]プロピル}−N,N−ジメチルアンモニ
ウム=クロライド 製造例5と同様にして得たN−[3−(ジメチルアミ
ノ)プロピル]−11−(デシルチオ)ウンデカンアミ
ド1.5gとベンジルクロライド0.5gをエタノール
20mlに溶解し、11時間還流した。溶媒を留去後、
生成物をエタノールから再結晶することにより標記化合
物1.8gを得た。 m.p.75〜77℃1 H−NMR(CDCl3) δ(ppm);0.88
(3H,t,J=6.5Hz),1.16〜1.70
(32H,m),2.13〜2.32(2H,m),
2.37(2H,t,J=7.8Hz),2.49(4
H,t,J=7.3Hz),3.19(6H,s),
3.35〜3.47(2H,m),3.85〜3.98
(2H,m),4.79(2H,s),7.41〜7.
63(5H,m),8.60(1H,br.s) ベンジルクロライドの代わりにプロピルブロマイドまた
はアリルブロマイドを用いて実施例4と同様に反応させ
ることにより以下の化合物を得た。 N−{3−[11−(デシルチオ)ウンデカンアミド]
プロピル}−N,N−ジメチル−N−プロピルアンモニ
ウム=ブロマイド m.p.70〜72℃ N−アリル−N−{3−[11−(ドデシルチオ)ウン
デカンアミド]プロピル}−N,N−ジメチルアンモニ
ウム=ブロマイド m.p.80〜82℃Example 4 N-benzyl-N- {3- [11- (decylthio) un]
Decanamide] propyl} -N, N-dimethylammoni
Um = chloride N- [3- (dimethylamino) propyl] -11- (decylthio) undecanoamide (1.5 g) obtained in the same manner as in Production Example 5 and benzyl chloride (0.5 g) were dissolved in ethanol (20 ml) and refluxed for 11 hours. did. After distilling off the solvent,
The product was recrystallized from ethanol to obtain 1.8 g of the title compound. m. p. 75-77 ° C. 1 H-NMR (CDCl 3 ) δ (ppm); 0.88
(3H, t, J = 6.5 Hz), 1.16 to 1.70
(32H, m), 2.13 to 2.32 (2H, m),
2.37 (2H, t, J = 7.8Hz), 2.49 (4
H, t, J = 7.3 Hz), 3.19 (6H, s),
3.35-3.47 (2H, m), 3.85-3.98
(2H, m), 4.79 (2H, s), 7.41-7.
63 (5H, m), 8.60 (1H, br.s) Propyl bromide or allyl bromide was used instead of benzyl chloride to carry out the reaction in the same manner as in Example 4 to obtain the following compound. N- {3- [11- (decylthio) undecanamide]
Propyl} -N, N-dimethyl-N-propylammonium bromide m. p. 70-72 ° C. N-allyl-N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N-dimethylammonium bromide m.p. p. 80-82 ° C
【0041】実施例5N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=メチルサルフェート 製造例5で得たN−[3−(ジメチルアミノ)プロピ
ル]−11−(ドデシルチオ)ウンデカンアミド2.0
gと硫酸ジメチル0.6gをメタノール30mlに溶解
し、2時間還流した。溶媒を留去後、生成物をメタノー
ルから再結晶することにより標記化合物2.4gを得
た。 m.p.90〜92℃1 H−NMR(CDCl3) δ(ppm)=;0.8
8(3H,t,J=6.5Hz),1.20〜1.69
(36H,m),2.02〜2.19(2H,m),
2.34(2H,t,J=7.7Hz),2.50(4
H,t,J=7.3Hz),3.24(9H,s),
3.33〜3.47(2H,m),3.58〜3.71
(2H,m),3.72(3H,s),8.07(1
H,br.s) 硫酸ジメチルの代わりにリン酸トリメチルを用いて実施
例5と同様に反応させることにより以下の化合物を得
た。 N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ジメチルホスフェート m.p.65〜67℃Example 5 N- {3- [11- (dodecylthio) undecanaami ]
De] propyl} -N, N, N-trimethylammonium
= M -Sulfate N- [3- (dimethylamino) propyl] -11- (dodecylthio) undecanamide 2.0 obtained in Production Example 5
g and 0.6 g of dimethyl sulfate were dissolved in 30 ml of methanol and refluxed for 2 hours. After evaporating the solvent, the product was recrystallized from methanol to obtain 2.4 g of the title compound. m. p. 90-92 ° C 1 H-NMR (CDCl 3 ) δ (ppm) =; 0.8
8 (3H, t, J = 6.5Hz), 1.20 to 1.69
(36H, m), 2.02 to 2.19 (2H, m),
2.34 (2H, t, J = 7.7Hz), 2.50 (4
H, t, J = 7.3 Hz), 3.24 (9H, s),
3.33 to 3.47 (2H, m), 3.58 to 3.71
(2H, m), 3.72 (3H, s), 8.07 (1
H, br. s) The following compounds were obtained by reacting in the same manner as in Example 5 except that trimethyl phosphate was used instead of dimethyl sulfate. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium dimethyl phosphate m. p. 65-67 ° C
【0042】実施例6N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=p−トルエンスルホネート 製造例5で得たN−[3−(ジメチルアミノ)プロピ
ル]−11−(ドデシルチオ)ウンデカンアミド1.5
gとp−トルエンスルホン酸メチル0.7gをエタノー
ル25mlに溶解し、2時間還流した。溶媒を留去後、
生成物をエタノールーエーテルで再結晶することにより
標記化合物1.6gを得た。 m.p.90〜92℃1 H−NMR(CDCl3) δ(ppm);0.88
(3H,t,J=6.5Hz),1.11〜1.66
(36H,m),1.98〜2.26(4H,m),
2.36(3H,s),2.50(4H,t,J=7.
3Hz),3.23(9H,s),3.29〜3.43
(2H,m),3.67〜3.81(2H,m),7.
18(2H,d,J=7.9Hz),7.72(2H,
d,J=8.1Hz),8.30(1H,br.s)Example 6 N- {3- [11- (dodecylthio) undecanaami ]
De] propyl} -N, N, N-trimethylammonium
= P-toluenesulfonate N- [3- (dimethylamino) propyl] -11- (dodecylthio) undecanamide 1.5 obtained in Production Example 5
g and 0.7 g of methyl p-toluenesulfonate were dissolved in 25 ml of ethanol and refluxed for 2 hours. After distilling off the solvent,
The product was recrystallized from ethanol-ether to obtain 1.6 g of the title compound. m. p. 90-92 ° C 1 H-NMR (CDCl 3 ) δ (ppm); 0.88
(3H, t, J = 6.5Hz), 1.11 to 1.66
(36H, m), 1.98-2.26 (4H, m),
2.36 (3H, s), 2.50 (4H, t, J = 7.
3 Hz), 3.23 (9 H, s), 3.29 to 3.43
(2H, m), 3.67 to 3.81 (2H, m), 7.
18 (2H, d, J = 7.9 Hz), 7.72 (2H,
d, J = 8.1 Hz), 8.30 (1H, br.s)
【0043】各種スルホン酸エステル及び硫酸エステル
を用いて実施例6と同様に反応させることにより以下の
化合物を得た。 N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=メチルスルホネート m.p.88〜90℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ベンゼンスルホネート m.p.86〜88℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=エチルサルフェート m.p.98〜100℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N−エチル−N,N−ジメチルアンモ
ニウム=エチルサルフェート m.p.52〜54℃The following compounds were obtained by reacting with various sulfonates and sulfates in the same manner as in Example 6. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium = methyl sulfonate m.p. p. 88-90 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium = benzenesulfonate m.p. p. 86-88 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium = ethylsulfate m.p. p. 98-100 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N-ethyl-N, N-dimethylammonium = ethylsulfate m.p. p. 52-54 ° C
【0044】実施例7N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ニトレート 実施例1で得たN−{3−[11−(ドデシルチオ)ウ
ンデカンアミド]プロピル}−N,N,N−トリメチル
アンモニウム=ヨーダイド1.5gをエタノール150
mlに溶解し、これに水15mlに溶解した硝酸銀0.
4gを加え、室温で15時間撹拌した。析出したヨウ化
銀を除き、溶媒を留去後生成物をエタノールから再結晶
することにより標記化合物0.5gを得た。 m.p.93〜95℃1 H−NMR(CDCl3) δ(ppm); 0.8
8(3H,t,J=6.5Hz),1.19〜1.69
(36H,m),2.00〜2.17(2H,m),
2.27(2H,t,J=7.5Hz),2.50(4
H,t,J=7.4Hz),3.27(9H,s),
3.30〜3.43(2H,m),3.64〜3.78
(2H,m),7.78(1H,br.s)Example 7 N- {3- [11- (dodecylthio) undecanaami ]
De] propyl} -N, N, N-trimethylammonium
= Nitrate N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium obtained in Example 1 = 1.5 g of iodide in 150 parts of ethanol.
0.1 ml of silver nitrate dissolved in 15 ml of water.
4 g was added, and the mixture was stirred at room temperature for 15 hours. The precipitated silver iodide was removed, the solvent was distilled off, and the product was recrystallized from ethanol to obtain 0.5 g of the title compound. m. p. 93-95 ° C 1 H-NMR (CDCl 3 ) δ (ppm); 0.8
8 (3H, t, J = 6.5 Hz), 1.19 to 1.69
(36H, m), 2.00 to 2.17 (2H, m),
2.27 (2H, t, J = 7.5Hz), 2.50 (4
H, t, J = 7.4 Hz), 3.27 (9H, s),
3.30-3.43 (2H, m), 3.64-3.78
(2H, m), 7.78 (1H, br.s)
【0045】各種銀塩を用いて実施例7と同様に反応さ
せることにより以下の化合物を得た。 N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=フロライド m.p.63〜65℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=クロライド m.p.93〜95℃ N−{3−[11−(ドデシルチオ)ウンデカンアミ
ド]プロピル}−N,N,N−トリメチルアンモニウム
=ニトリト m.p.94〜96℃The following compounds were obtained by reacting with various silver salts in the same manner as in Example 7. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium fluoride m.p. p. 63-65 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium chloride m.p. p. 93-95 ° C. N- {3- [11- (dodecylthio) undecanamido] propyl} -N, N, N-trimethylammonium nitrite m.p. p. 94-96 ° C
【0046】(試験例) 発毛効果試験 アルカンアミドアンモニウム化合物の発毛効果試験は、
C3Hマウス(雄,7週令)5匹を一群として用い、そ
の背部毛をバリカンで除毛し、その部位に1日1回、表
1に示した試料0.2mlを10日間塗布し、その後の
発毛程度を下記の6段階で肉眼により評価した。 発毛が認められない 0点 わずかな軟毛が生えている 1点 わずかな硬毛が生えている 2点 硬毛が除毛部位の25%に生えている 3点 硬毛が除毛部位の50%に生えている 4点 硬毛が除毛部位の75%に生えている 5点 硬毛が除毛部位の100%に生えている 6点 試料塗布開始後42日後の結果を評価点の平均値で表2
に示す。(Test Example) Hair Growth Effect Test The hair growth effect test of the alkanamide ammonium compound is as follows.
Five C3H mice (male, 7 weeks old) were used as a group, their back hairs were hair-removed, and 0.2 ml of the sample shown in Table 1 was applied to the site once a day for 10 days. The degree of hair growth was evaluated visually with the following 6 grades. No hair growth is observed 0 points Slight vellus hair is growing 1 point Slight bristles are growing 2 points Bristles are growing on 25% of the hair removal site 3 points Hair bristles are 50 parts of the hair removal site % 5% bristles grow on 75% of the hair removal site 5 points Bristles grow on 100% of the hair removal site 6 points The result after 42 days from the start of sample application is the average of the evaluation points. Table 2 by value
Shown in.
【0047】[0047]
【表1】 [Table 1]
【0048】[0048]
【表2】 [Table 2]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 松本 太郎 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内 (72)発明者 畑山 勝男 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Taro Matsumoto 3-24-1 Takada, Toshima-ku, Tokyo Taisho Pharmaceutical Co., Ltd. (72) Inventor Katsuo Hatayama 3-24-1 Takada, Toshima-ku, Tokyo Taisho Within Pharmaceuticals Co., Ltd.
Claims (1)
は炭素原子数3〜8のシクロアルキル基を示し、R2は
炭素原子数1〜15のアルキレン基を示し、R3は水素
原子または低級アルキル基を示し、R4は炭素原子数2
〜10のアルキレン基を示し、R5及びR6は同一また
は異なって低級アルキル基を示し、R7は炭素原子数1
〜22のアルキル基、炭素原子数2〜10のアルケニル
基または「フェニル基で置換された低級アルキル基」を
示し、Aは酸素原子または 【化2】 (化2中、nは0〜2の整数を示す。)で表される基を
示し、Xは陰イオンとなる原子または原子団を示す。]
で表されるアルカンアミドアンモニウム化合物。Claims: [In Chemical Formula 1 , R 1 represents an alkyl group having 1 to 22 carbon atoms or a cycloalkyl group having 3 to 8 carbon atoms, R 2 represents an alkylene group having 1 to 15 carbon atoms, and R 3 represents hydrogen. Represents an atom or a lower alkyl group, and R 4 has 2 carbon atoms
-10 is an alkylene group, R 5 and R 6 are the same or different and each is a lower alkyl group, and R 7 is a carbon atom of 1
To 22 alkyl group, alkenyl group having 2 to 10 carbon atoms or “lower alkyl group substituted with phenyl group”, A is an oxygen atom or (Wherein n represents an integer of 0 to 2 in Chemical Formula 2), X represents an atom or an atomic group which becomes an anion. ]
Alkaneamido ammonium compound represented by.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3287374A JPH0543529A (en) | 1991-08-10 | 1991-08-10 | Alkaneamide ammonium compound |
CA002115345A CA2115345A1 (en) | 1991-08-10 | 1992-08-07 | Alkanamidoammonium compounds |
PCT/JP1992/001014 WO1993003005A1 (en) | 1991-08-10 | 1992-08-07 | Alkanamidoammonium compound |
AU24027/92A AU656625B2 (en) | 1991-08-10 | 1992-08-07 | Alkanamidoammonium compound |
CN93101376A CN1082534A (en) | 1991-08-10 | 1993-02-10 | Alkanoylamide Ammonium Compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3287374A JPH0543529A (en) | 1991-08-10 | 1991-08-10 | Alkaneamide ammonium compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0543529A true JPH0543529A (en) | 1993-02-23 |
Family
ID=17716536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3287374A Pending JPH0543529A (en) | 1991-08-10 | 1991-08-10 | Alkaneamide ammonium compound |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPH0543529A (en) |
CN (1) | CN1082534A (en) |
AU (1) | AU656625B2 (en) |
CA (1) | CA2115345A1 (en) |
WO (1) | WO1993003005A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610198A (en) * | 1994-03-18 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases |
FR2778405B1 (en) * | 1998-05-07 | 2000-09-08 | Ceca Sa | N- (DIALKYLAMINO) ALKYL ALPHA CARBOXAMIDES, COMPOSITIONS CONTAINING THEM, METHODS OF PREPARATION AND USES |
EP0965584A3 (en) * | 1998-06-15 | 2003-12-17 | Transgene S.A. | Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell |
EP0965583A1 (en) * | 1998-06-15 | 1999-12-22 | Transgene S.A. | Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell |
WO2009061208A1 (en) | 2007-11-09 | 2009-05-14 | Pronova Biopharma Norge As | Lipid compounds for use in cosmetic products, as food supplement or as a medicament |
EP2147910A1 (en) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
JP5843755B2 (en) | 2009-05-08 | 2016-01-13 | プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma Norge AS | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
PH12013500893A1 (en) | 2010-11-05 | 2013-07-15 | Pronova Biopharma Norge As | Methods of treatment using lipid compounds |
ES2748562T3 (en) | 2013-02-28 | 2020-03-17 | Basf As | A composition comprising a lipid compound, a triglyceride and a surfactant, and methods of using the same |
CA2983377C (en) | 2015-04-28 | 2023-08-29 | Pronova Biopharma Norge As | Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis |
SG11202005007VA (en) | 2017-12-06 | 2020-06-29 | Basf As | Fatty acid derivatives for treating non-alcoholic steatohepatitis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1002534A (en) * | 1973-06-27 | 1976-12-28 | Donald E. Conner | Quaternary halides of gluconamides |
JPS54130509A (en) * | 1977-06-29 | 1979-10-09 | Procter & Gamble | Organism decomposing cationic surfactant |
-
1991
- 1991-08-10 JP JP3287374A patent/JPH0543529A/en active Pending
-
1992
- 1992-08-07 AU AU24027/92A patent/AU656625B2/en not_active Expired - Fee Related
- 1992-08-07 WO PCT/JP1992/001014 patent/WO1993003005A1/en active Application Filing
- 1992-08-07 CA CA002115345A patent/CA2115345A1/en not_active Abandoned
-
1993
- 1993-02-10 CN CN93101376A patent/CN1082534A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1082534A (en) | 1994-02-23 |
AU656625B2 (en) | 1995-02-09 |
AU2402792A (en) | 1993-03-02 |
CA2115345A1 (en) | 1993-02-18 |
WO1993003005A1 (en) | 1993-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7351716B2 (en) | Dermatological preparations | |
US5449805A (en) | Intermediates for preparing alkylamino mercaptoalkylamides | |
US4939171A (en) | Sebosuppressive topical preparations | |
JPH0543529A (en) | Alkaneamide ammonium compound | |
DE69611444T2 (en) | AMID DERIVATIVES AND COMPOSITIONS FOR EXTERNAL SKIN AND HAIR CARE | |
JPWO2007034750A1 (en) | Wrinkle improver | |
EP0408442B1 (en) | Halogenated pyrimidin-3-oxyde derivatives, their use for the treatment and the prevention of hairloss and for stimulating growth again | |
EP0679628A1 (en) | Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use | |
US5230890A (en) | Urethane derivatives from amino acids, a process for their preparation and cosmetic or pharmaceutical compositions for use in the treatment of dry skin | |
US4590069A (en) | Novel substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same | |
US5935585A (en) | Biaromatic amido compounds and pharmaceutical/cosmetic compositions comprised thereof | |
EP0522506A2 (en) | Ester compound and cosmetic preparation comprising the same | |
CA1134824A (en) | Cosmetic composition for the treatment of seborrhea, novel composition and preparation process | |
FR2677983A1 (en) | ALKYLTHIOPOLY (ETHYLIMIDAZOLIUM) COMPOUNDS, PREPARATION METHOD AND THEIR USE AS BIOCIDAL AGENTS. | |
JPH0543530A (en) | Alkanamide carboxybetaine | |
US5714630A (en) | Serine compounds, their preparation and their use in cosmetic or dermatological compositions | |
US5583154A (en) | Method for enhancing hair growth | |
JP4112741B2 (en) | Moisturizer | |
JPH06145123A (en) | Amide derivative and its production intermediate, and skin external preparation containing the amide derivative | |
CA1300642C (en) | Eicosatetraynoic - 5,8,11,14 acid preparation process | |
JP3073813B2 (en) | Cosmetics | |
US5741915A (en) | Meadowfoam betaines | |
JP4220625B2 (en) | External preparation composition | |
JP3441665B2 (en) | (2-Substituted oxyphenyl) alkaneamide derivatives, hair tonics, skin external preparations | |
US5932754A (en) | Meadowfoam quaternary compounds |